Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years
Clinical trial NCT00719043 · COMPLETED
Trial details
- NCT number
- NCT00719043
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-11
- Primary completion
- 2010-04-22
- Enrollment
- 841
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.